Andrea Cote is a PhD student in the lab of Dr. Alison Ringel at the Ragon Institute of MGH, MIT and Harvard, with an expected graduation date in May 2026. Prior experience includes serving as an Associate Scientist in Lentiviral Vector Engineering at ElevateBio and as an Undergraduate Research Assistant at the UNH - Dr. Brian Barth AML Research Lab, where contributions involved researching anticancer compounds and collaborating on projects regarding therapeutic effects for AML. Additional roles in the culinary field include baking for Swweetened Memories and assisting chefs at Bianco's Catering. Andrea holds a Bachelor of Science in Biochemistry, Molecular and Cellular Biology from the University of New Hampshire.
This person is not in the org chart
Ragon Institute of Mass General, MIT, and Harvard
1 followers
The Ragon Institute was established in 2009 with a dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently establish itself as a world leader in the collaborative study of immunology. Founded with a commitment of $100 million from Phillip T. (Terry) and Susan M. Ragon, and with an additional $200 million gift to endow the Institute announced on April 26, 2019, the Institute is structured and positioned to significantly contribute to a global effort to successfully develop an HIV/AIDS vaccine by: • Creating non-traditional partnerships among experts with different but complementary backgrounds; • Providing a means for rapidly funding promising studies; • Integrating key facets of vaccine development efforts that have tended to follow separate tracks; • Providing a substantial pool of accessible, flexible funding that lowers the threshold for scientists to pursue risky, unconventional avenues of study that are unlikely to attract funding from traditional sources. Such funding encourages innovation, compresses the time it takes to conduct bench-to-bedside research and attracts new minds to the field. The Ragon Institute creates a singular opportunity and environment to engage scientists, engineers and clinicians in challenging research for which there is no greater benefit – saving lives and curing the ill.